Glomerulonephritis, Membranoproliferative

Displaying 1 - 5 of 5CSV
Kudose, S., Batal, I., Lucia, J., Patel, P., Soni, R. K., Markowitz, G. S., D’Agati, V. D., & Stokes, M. B. (2023). Proliferative Glomerulonephritis With Hidden Monotypic IgG3κ Deposits: A Case Report. American Journal of Kidney Diseases, 81(1), 114–117. https://doi.org/10.1053/j.ajkd.2022.05.018
Publication Date
Podos, S. D., Trachtman, H., Appel, G. B., Bomback, A. S., Dixon, B. P., Wetzels, J. F. M., Cook, H. T., Parikh, S. V., Pickering, M. C., Tumlin, J., Langman, C. B., Lightstone, L., Sperati, C. J., Daina, E., Bouman, K. P., Rice, K., Thanassi, J. A., Huang, M., Nester, C., & Remuzzi, G. (2022). Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan. American Journal of Nephrology, 53(10), 675–686. Portico. https://doi.org/10.1159/000527166
Publication Date
Nester, C., Appel, G. B., Bomback, A. S., Bouman, K. P., Cook, H. T., Daina, E., Dixon, B. P., Rice, K., Najafian, N., Hui, J., Podos, S. D., Langman, C. B., Lightstone, L., Parikh, S. V., Pickering, M. C., Sperati, C. J., Trachtman, H., Tumlin, J., de Vries, A. P., … Remuzzi, G. (2022). Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies. American Journal of Nephrology, 53(10), 687–700. Portico. https://doi.org/10.1159/000527167
Publication Date
Lomax-Browne, H. J., Medjeral-Thomas, N. R., Barbour, S. J., Gisby, J., Han, H., Bomback, A. S., Fervenza, F. C., Cairns, T. H., Szydlo, R., Tan, S.-J., Marks, S. D., Waters, A. M., Appel, G. B., D’Agati, V. D., Sethi, S., Nast, C. C., Bajema, I., Alpers, C. E., Fogo, A. B., … Pickering, M. C. (2022). Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis. Clinical Journal of the American Society of Nephrology, 17(7), 994–1007. https://doi.org/10.2215/cjn.16801221
Publication Date